RBOT (Vicarious Surgical) Ending Cash Position: $2.09 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vicarious Surgical Ending Cash Position?

Vicarious Surgical RBOT -6.35% Ending Cash Position is $2.09 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

Vicarious Surgical's Ending Cash Position for the quarter that ended in Mar. 2026 was $2.09 Mil.

Vicarious Surgical's quarterly Ending Cash Position declined from Sep. 2025 ($4.10 Mil) to Dec. 2025 ($3.51 Mil) and declined from Dec. 2025 ($3.51 Mil) to Mar. 2026 ($2.09 Mil).

Vicarious Surgical's annual Ending Cash Position declined from Dec. 2023 ($53.76 Mil) to Dec. 2024 ($10.67 Mil) and declined from Dec. 2024 ($10.67 Mil) to Dec. 2025 ($3.51 Mil).

Vicarious Surgical Ending Cash Position Related Terms

Vicarious Surgical Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Vicarious Surgical's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vicarious Surgical Ending Cash Position Chart

Vicarious Surgical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 174.56 117.14 53.76 10.67 3.51

Vicarious Surgical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.54 4.85 4.10 3.51 2.09

Vicarious Surgical Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Vicarious Surgical's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=10.673+-7.168
=3.51

Vicarious Surgical's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=3.505+-1.419
=2.09

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $2.09 Mil mean?
Vicarious Surgical (RBOT) has a Ending Cash Position of $2.09 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Vicarious Surgical and its competitors.
Is Vicarious Surgical's Ending Cash Position too high?
Vicarious Surgical's current Ending Cash Position is $2.09 Mil.
How does Vicarious Surgical's Ending Cash Position compare to NUWE and ODYY?
Vicarious Surgical's Ending Cash Position of $2.09 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Vicarious Surgical and its competitors. Vicarious Surgical's current Ending Cash Position is $2.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vicarious Surgical stock overvalued right now?
Vicarious Surgical (RBOT) has a current Ending Cash Position of $2.09 Mil. The current Ending Cash Position is $2.09 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Vicarious Surgical (RBOT), the current Ending Cash Position is $2.09 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vicarious Surgical Business Description

Address 78 Fourth Avenue, Waltham, MA, USA, 02451
Vicarious Surgical Inc is combining miniaturized robotics, computer science, sensing and 3D visualization to build a new category of intelligent and affordable single-port surgical robots that virtually transport surgeons inside the patient to perform minimally invasive surgery. Its single-port surgical robot, called the Vicarious Surgical System is being developed to provide attractive advantages to hospitals and ambulatory surgical centers, or ASCs, which it believes will drive rapid and widespread adoption. The company operates as one operating segment.